Tiffany Garbutt, PhD, Author at Oncology Nurse Advisor https://www.oncologynurseadvisor.com Tue, 21 Jan 2020 22:22:33 +0000 en-US hourly 1 https://wordpress.org/?v=6.4.3 https://www.oncologynurseadvisor.com/wp-content/uploads/sites/13/2024/01/cropped-CTA-ONA-HEM-favicon-32x32.png Tiffany Garbutt, PhD, Author at Oncology Nurse Advisor https://www.oncologynurseadvisor.com 32 32 Treatment With PI3K Inhibitors Is Associated With a Number of Adverse Events and Toxicities https://www.oncologynurseadvisor.com/home/headlines/conference-coverage/ash-2019/treatment-with-pi3k-inhibitors-associated-with-adverse-events-and-toxicities/ Tue, 10 Dec 2019 21:00:22 +0000 https://www.oncologynurseadvisor.com/?p=70852 Clinical researchDespite improved survival in patients with B cell malignancies who are treated with PI3K inhibitors, researchers found incidences of pneumonitis, infections, and sepsis are higher in these patients.]]> Many Young Adult Hematopoietic Cell Transplant Survivors May Need Return-to-Work Interventions Post Transplant https://www.oncologynurseadvisor.com/home/headlines/conference-coverage/ash-2019/young-adult-hct-survivors-may-need-help-returning-to-work-post-transplant/ Tue, 10 Dec 2019 16:30:55 +0000 https://www.oncologynurseadvisor.com/?p=70833 Diagnosing a younger patient.Data from the CIBMTR demonstrate a need to develop return-to-work interventions for patients who have undergone HCT as treatment of malignant, as well as nonmalignant, conditions.]]> Monitoring Disease Recurrence With Patient-Reported Outcomes After Discontinuation of Tyrosine Kinase Inhibitor Therapy https://www.oncologynurseadvisor.com/home/headlines/conference-coverage/ash-2019/monitoring-disease-recurrence-with-pros-after-discontinuing-tki-therapy/ Tue, 10 Dec 2019 16:15:09 +0000 https://www.oncologynurseadvisor.com/?p=70830 A recent article is only the latest in a series of studies drawing attention to the importance of diResults of LAST, the largest study on TKI discontinuation, support using patient-reported outcomes when monitoring remission and symptoms in patients who discontinue TKI therapy.]]> Assessing VTE Risk Based on Presence of Elevated Biomarkers Provides Better Risk Stratification Than Current Methods https://www.oncologynurseadvisor.com/home/headlines/conference-coverage/ash-2019/elevated-biomarkers-provides-better-assessment-of-vte-risk-in-cancer-pts/ Mon, 09 Dec 2019 17:18:40 +0000 https://www.oncologynurseadvisor.com/?p=70801 An illustration of a thrombosis forming.New scoring method provides a more nuanced risk stratification of VTE than the Khorana score in ambulatory patients with cancer. ]]> Broad-Spectrum Antibiotics Do Not Appear to Significantly Increase Risk of Acute Graft-Versus-Host Disease https://www.oncologynurseadvisor.com/home/headlines/conference-coverage/ash-2019/broad-spectrum-antibiotics-did-not-significantly-increase-risk-of-agvhd/ Mon, 09 Dec 2019 16:28:10 +0000 https://www.oncologynurseadvisor.com/?p=70792 A young patient with cancer.Researchers explored the effect of using antibiotics commonly used to treat neutropenic fever on likelihood of aGVHD developing in younger patients who underwent HCT for acute leukemia.]]> Risk of Cardiac Heart Failure, Arrhythmia Increased With Anthracycline for Lymphoma https://www.oncologynurseadvisor.com/home/headlines/conference-coverage/ash-2019/risk-of-cvd-increased-with-anthracycline-for-lymphoma/ Sun, 08 Dec 2019 15:00:59 +0000 https://www.oncologynurseadvisor.com/?p=70743 Heart rate monitor in an intensive care unit.A prospective study followed more than 3000 patients with lymphoma to determine the potential risk for developing anthracycline-induced CVD.]]> Higher Comorbidities Not Likely to Blame for Underrepresentation of African Americans in Clinical Trials, Studies of Acute Myeloid Leukemia https://www.oncologynurseadvisor.com/home/headlines/conference-coverage/ash-2019/higher-comorbidities-not-why-blacks-underrepresented-in-aml-studies/ Sun, 08 Dec 2019 13:15:22 +0000 https://www.oncologynurseadvisor.com/?p=70735 Reviewing a patient's historyResearchers sought to determine if presence of comorbidities influences the underrepresentation of African American patients with acute myeloid leukemia in clinical trials.]]> Tandem Transplant Strategies Associated With Higher Progression-Free Survival in Patients With Multiple Myeloma https://www.oncologynurseadvisor.com/home/headlines/conference-coverage/ash-2019/tandem-transplant-strategies-associated-with-higher-pfs-in-pts-with-mm/ Sun, 08 Dec 2019 13:00:11 +0000 https://www.oncologynurseadvisor.com/?p=70732 Discussing lifestyle changes with a cancer survivor.This retrospective analysis compared auto-HSCT and allo-HSCT with tandem auto-HSCT and auto-allo-HSCT to determine which strategy provided better PFS and OS for patients with multiple myeloma.]]> Corticosteroids May Be Effective for Managing Cytokine Release Syndrome Associated With CAR-T Therapy https://www.oncologynurseadvisor.com/home/headlines/conference-coverage/ash-2019/corticosteroids-may-be-effective-for-managing-crs-associated-with-car-t-therapy/ Sat, 07 Dec 2019 20:30:53 +0000 https://www.oncologynurseadvisor.com/?p=70723 Muscle achesResearchers sought to determine if corticosteroids can be used to effectively manage CRS in patients undergoing CAR-T therapy without negatively influencing outcomes.]]> Early Steroid Use May Mitigate Adverse Effects Associated With Axicabtagene Ciloleucel CAR-T Therapy https://www.oncologynurseadvisor.com/home/headlines/conference-coverage/ash-2019/early-steroid-use-may-mitigate-aes-associated-with-axi-cel-car-t-therapy/ Sat, 07 Dec 2019 20:00:39 +0000 https://www.oncologynurseadvisor.com/?p=70707 Illustration of CAR-T cell immunotherapyIn a safety expansion of the ZUMA-1 study, researchers found that steroids may reduce incidence of CRS and neurologic events associated with CAR-T therapy in patients with relapsed/refractory large B cell lymphoma.]]>